Malaria – Parasite, Vector and the ongoing battle against a silent killer

Malaria, a mosquito-borne infectious disease, continues to pose a significant threat to human health in many parts of the world. Despite advancements in medicine and global efforts to combat the disease, malaria remains a leading cause of illness and mortality, particularly in tropical and subtropical regions. This article explores the causes, symptoms, prevention, and ongoing efforts to eradicate malaria.

Understanding Malaria:

Malaria is caused by a parasite of the Plasmodium species, transmitted to humans through the bite of infected female Anopheles mosquitoes. Five species of Plasmodium parasites (P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi) can cause malaria in humans, with P. falciparum being the most dangerous and responsible for the majority of malaria-related deaths worldwide.

Symptoms and Impacts:
Malaria presents with flu-like symptoms such as high fever, chills, headaches, muscle aches, and fatigue. If left untreated or misdiagnosed, it can lead to severe complications, including organ failure, anemia, cerebral malaria, and even death. Pregnant women, young children, and individuals with weakened immune systems are particularly vulnerable to severe malaria.

The Vector:

the term “mosquito” often invokes annoyance and discomfort, the female
Anopheles mosquito holds a particularly notorious distinction as the
primary carrier of the deadly malaria parasite. Understanding the
biology, behavior, and role of these mosquitoes is crucial in combating
the spread of malaria. This article delves into the fascinating world of
the female Anopheles mosquito and its intricate relationship with
malaria transmission.


Biology of the Female Anopheles Mosquito:
Among the various mosquito species, it is the female Anopheles mosquito
that poses the greatest threat to human health. These mosquitoes belong
to the Culicidae family and have distinct physical characteristics,
including slender bodies, elongated mouthparts (proboscis), and unique
wing patterns that aid in species identification.

Transmission Cycle: 

The female Anopheles mosquito’s connection to malaria lies in its role
as a vector, or carrier, of the Plasmodium parasite. The transmission
cycle begins when an infected mosquito feeds on a human host. Within the
mosquito, the parasite undergoes complex developmental stages before
eventually migrating to the salivary glands. When the mosquito
subsequently bites another person, it injects the parasites along with
its saliva, initiating a new infection.

Habits and Behavior: 

Unlike their male counterparts, female Anopheles mosquitoes require
blood meals to obtain the necessary nutrients for egg development. They
exhibit crepuscular feeding behavior, being most active during dawn and
dusk. The mosquitoes are attracted to human hosts by a combination of
factors, including body heat, carbon dioxide emissions, and chemical
signals like lactic acid and ammonia found in human sweat.

Sites and Environmental Factors:
Female Anopheles mosquitoes typically breed in stagnant water sources
such as ponds, marshes, and even small collections of water in man-made
containers. They lay their eggs on the water’s surface, and the larvae,
known as wrigglers or wigglers, develop in the aquatic environment.
Environmental factors, such as temperature, humidity, and availability
of suitable breeding sites, greatly influence the mosquito population’s
abundance and distribution.

The Plasmodium Parasite and Malaria: 

Malaria, a life-threatening disease, is caused by Plasmodium parasites. These unicellular organisms belong to the Phylum Apicomplexa and exhibit complex life cycles involving both mosquito vectors and human hosts. Among the numerous Plasmodium species, five are known to infect humans: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi. Each species has its distinct characteristics and implications for disease severity.

  1. Plasmodium falciparum:
    P. falciparum is the most lethal species, responsible for the majority of malaria-related deaths worldwide. It thrives in tropical and subtropical regions and causes severe malaria cases. The parasites have a short life cycle, rapidly multiplying within red blood cells and leading to the destruction of these cells. Complications such as organ failure, cerebral malaria, and anemia are common with P. falciparum infections.
  2. Plasmodium vivax:
    P. vivax is the most widespread species outside of Africa and accounts for a significant portion of malaria cases globally. Although less deadly than P. falciparum, P. vivax infections can cause relapses due to the presence of dormant liver-stage parasites (hypnozoites). This unique characteristic poses challenges for complete treatment and disease elimination.
  3. Plasmodium malariae:
    P. malariae
    is known for causing chronic, low-level malaria infections. It has a longer life cycle compared to other Plasmodium species, with infected individuals experiencing prolonged periods of parasitemia. While less severe, P. malariae can contribute to long-term health complications, such as kidney disease.
  4. Plasmodium ovale:
    P. ovale infections are relatively rare but have a geographical distribution overlapping with P. vivax. Like P. vivax, P. ovale can form dormant liver-stage parasites, leading to potential relapses. However, these relapses are less frequent compared to P. vivax infections.
  5. Plasmodium knowlesi:
    Originally found in macaque monkeys, P. knowlesi can infect humans and cause malaria. This species has gained attention due to its potential for severe illness and complications. P. knowlesi infections are prevalent in certain regions of Southeast Asia and can be misdiagnosed as other types of malaria, further complicating control efforts.

Prevention and Control Measures:

Preventing malaria requires a multifaceted approach. Key preventive strategies include the use of insecticide-treated bed nets, indoor residual spraying to kill mosquitoes, and the administration of antimalarial drugs to at-risk populations. Education and awareness campaigns play a crucial role in teaching communities about the importance of preventive measures and early diagnosis and treatment.

Advancements in Malaria Control:
In recent years, significant progress has been made in the fight against malaria. Improved diagnostics and rapid diagnostic tests have enabled more accurate and timely detection of the disease. Artemisinin-based combination therapies (ACTs) have proven effective in treating uncomplicated malaria cases, reducing morbidity and mortality rates.

Additionally, research efforts have focused on developing malaria vaccines, with the most advanced candidate being the RTS,S/AS01 vaccine, which has shown promising results in clinical trials. However, the challenge remains to ensure widespread access and affordability of these vaccines, especially in regions most affected by the disease.

Global Initiatives and Collaborative Efforts:
The global community has recognized the urgency of tackling malaria and has committed to ambitious goals for its elimination. The World Health Organization’s (WHO) Global Malaria Program, along with international partners, works towards reducing malaria cases and deaths by providing technical assistance, coordinating response efforts, and facilitating resource mobilization.

Furthermore, initiatives such as the Roll Back Malaria Partnership and the President’s Malaria Initiative (PMI) have played pivotal roles in funding research, providing prevention tools, and strengthening health systems in malaria-endemic regions.

Challenges Ahead:
Despite progress, several challenges hinder malaria elimination efforts. Insecticide resistance, limited access to healthcare facilities, inadequate funding, and climate change influencing mosquito populations are among the obstacles faced. Furthermore, the ongoing COVID-19 pandemic has diverted resources and disrupted malaria control programs, exacerbating the burden of the disease.

The Way Forward:

Sustained commitment and investment are vital to overcome the challenges posed by malaria. Strengthening healthcare infrastructure, improving access to diagnostics and treatment, and integrating malaria control measures into existing health systems are crucial steps forward. Additionally, research and innovation must continue to develop new tools, such as more effective antimalarial drugs, insecticides, and vaccines.


Graduated from the University of Kerala with B.Sc. Botany and Biotechnology. M.Sc. Biotechnology from the University of Kerala. Attended certificate course in Artificial Intelligence for Everyone from Deeplearning.AI, Influenza Prevention and Control from World Health Organization. Attended workshops related to Bioinformatics at the University of Kerala. 3 years of experience in website management. Experience in WordPress, Blogger, Google Analytics, and Google Search Console.

Achuth B S

Graduated from the University of Kerala with B.Sc. Botany and Biotechnology. M.Sc. Biotechnology from the University of Kerala. Attended certificate course in Artificial Intelligence for Everyone from Deeplearning.AI, Influenza Prevention and Control from World Health Organization. Attended workshops related to Bioinformatics at the University of Kerala. 3 years of experience in website management. Experience in WordPress, Blogger, Google Analytics, and Google Search Console.

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Next Generation Sequencing (NGS) and its application in genomics

Tue Jun 27 , 2023
    Sanger sequencing, the primary approach of DNA sequencing since its inception in the 1970s, was used to complete the sequencing of the human genome in 2003. The need for rapid, cost-effective, and reliable analysis of vast amounts of genomic DNA is driving a massive increase in the demand […]

Related Articles